Company

Shenyang Xingqi Pharmaceutical Co. Ltd

Headquarters: Shenyang, China

Employees: 1,102

SZSE: 300573 -4.31%

Market Cap

CN¥12.83 Billion

CNY as of July 1, 2025

US$1.79 Billion

Market Cap History

Shenyang Xingqi Pharmaceutical Co. Ltd market capitalization over time

Evolution of Shenyang Xingqi Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Shenyang Xingqi Pharmaceutical Co. Ltd

Detailed Description

Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.

Financials

Last Financial Reports Date March 31, 2025
Revenue TTM CN¥2.13 B
EBITDA CN¥556.2 M
Gross Profit TTM CN¥1.68 B
Profit Margin 21.09%
Operating Margin 34.59%
Quarterly Revenue Growth 53.20%
Financial Reports & Statistics

Stocks & Indices

Shenyang Xingqi Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300573 wb_incandescent

Details

Headquarters:

No. 68, Lishui Street

Dongling District

Shenyang, None

China

Phone: 86 24 8802 6022

Fax: 86 24 8802 6058